XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.4

6. FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Table of fair value liability measured on recurring basis

The following table presents the placement in the fair value hierarchy and summarizes the change in fair value of the earn-out consideration for Fiscal 2020 and Fiscal 2019:

						Fair value measurement at reporting date using
						Quoted prices in active markets for identical assets				Significant other observable inputs				Significant unobservable inputs
		Balance				(Level 1)				(Level 2)				(Level 3)
September 30, 2018		$	538,000			$	–			$	–			$	538,000
Increase in fair value of IPS deferred cash consideration			36,000				–				–				36,000
Increase in fair value of IPS earn-out consideration			260,000				–				–				260,000
September 30, 2019			834,000				–				–				834,000
Increase in fair value of IPS deferred cash consideration			16,000				–				–				16,000
Decrease in the fair value of IPS earnout consideration			(350,000	)			–				–				(350,000	)
Payout of IPS deferred cash consideration			(500,000	)			–				–				(500,000	)
Fair value of Kablooe contingent earnout consideration			90,000				–				–				90,000
September 30, 2020		$	90,000			$	–			$	–			$	90,000

Fair value assumptions

The fair value of the Kablooe contingent earn-out consideration will be measured on a recurring basis at each reporting date. The following inputs and assumptions were used in the Black-Scholes valuation model to estimate the fair value of the Kablooe earn-out consideration at September 30, 2020:

Volatility		40%
Risk free interest rate		1%
Expected term, in years		0.5 - 4.5
Dividend yield		0%

Schedule of Cost Method Investments

The following table presents the placement in the fair value hierarchy and summarizes the change in fair value of the cost method investment during Fiscal 2020 and Fiscal 2019:

						Fair value measurement at reporting date using
						Quoted prices in active markets for identical assets				Significant other observable inputs				Significant unobservable inputs
		Balance				(Level 1)				(Level 2)				(Level 3)
September 30, 2019		$	327,000			$	–			$	327,000			$	–
Impairment of cost method investment			(327,000	)			–				(327,000	)			–
September 30, 2020		$	–			$	–			$	–			$	–

X

- Definition

Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_FairValueDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

A tabular disclosure of (a) the aggregate carrying amount of all cost-method investments; (b) the aggregate carrying amount of cost-method investments that the investor did not evaluate for impairment for cost-method investments.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCostMethodInvestmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration